Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,502 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05556460Recruiting
Device trial for fixing severe tricuspid valve leakage without surgery
This trial tests the DragonFly-T system to improve symptoms and heart function in people with severe tricuspid regurgitation (a leaky heart valve) using a catheter-based repair. It may help reduce valve leak–related symptoms when standard medication isn’t enough and surgery risk is higher.
Chengdu, SichuanAges 18 years+ - NCT05563363Recruiting
Home-based treatment for severe addiction problems
This trial tests a home-based treatment approach for adults with severe substance use problems. It may help you and your care team manage addiction with structured support while you stay at home.
GenevaAges 18 years+ - NCT05565222RecruitingPhase 3
Testing two antibiotics as alternatives for ICU severe ESBL infections
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
ParisAges 18 years+ - NCT05566431Recruiting
Check monitoring for high brain pressure after child head injury
This study looks at a way of measuring and responding to high pressure inside the brain in children after a non-penetrating head injury. It may help doctors decide which monitoring approach works best for children who are very sick right after injury or become worse quickly.
Seattle, WashingtonAges 1–12 - NCT05568069Recruiting
Study of defibrillator implants for non-ischemic weak heart
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
High Wycombe, BuckinghamshireAges 18 years+ - NCT05582993RecruitingPhase 3
Study of rVWF for severe bleeding disorder in children
This Phase 3 trial tests vonicog alfa (an rVWF treatment) to prevent and control bleeding in children with severe von Willebrand disease (vWD). You may be able to join if your child has severe vWD and has been on prior clotting factor treatment with ongoing bleeding despite that care.
Birmingham, AlabamaAges Up to 17 years - NCT05582915Recruiting
Checking blood tests and scans to predict severe Bell’s palsy
This study looks for early “prognostic biomarkers” (measurable signs in blood/tissue or scans) to predict how severe Bell’s palsy will turn out. It may help doctors better choose the right treatment and follow-up for adults with severe facial nerve weakness.
MontpellierAges 18 years+ - NCT05631405Recruiting
Dexamethasone for serious dengue with warning signs
This trial studies whether dexamethasone (a steroid medicine) can help people with dengue infection who have warning signs and are still in the fever stage. It may help reduce complications like breathing problems, severe bleeding, or organ stress, but it is only for a specific window and situation.
BangkokAges 7–99 - NCT05635929Recruiting
Topical treatment to reduce mouth sores during or after radiation
This study tests a new cream/gel applied to the mouth to lower the chance of severe mouth sores in people receiving radiation for head and neck cancer. It also looks at how treatment affects quality of life using patient questionnaires.
Madrid, MadridAges 18 years+ - NCT05642182RecruitingPhase 1
Study drug trial for mild to moderate plaque psoriasis
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
Pompano Beach, FloridaAges 18 years+ - NCT05644782Recruiting
Diet study for mild-to-moderate psoriasis in adults
This trial studies whether a dietary approach can help people with mild-to-moderate psoriasis. It may be especially focused on people who do not have signs of wheat/gluten-related immune reactions.
Palermo, PalermoAges 18–65 - NCT05651113Recruiting
Your experience during screening for SCID
This study looks at what it feels like for people to go through screening for SCID (a rare immune condition). It may help improve the screening process and support for patients and families.
LondonAges 18 years+ - NCT05661461RecruitingPhase 1
Test drug dosing and safety for advanced cancers with liver issues
This Phase 1 study tests different doses of nab-sirolimus to see if it is safe and how the body processes it. It is for people with advanced or metastatic solid tumors who also have moderate liver impairment.
San Antonio, TexasAges 18 years+ - NCT05681585Recruiting
Advance care planning for very frail older adults at home
This study looks at advance care planning (talking ahead about care goals and preferences) for very frail people who are living at home after a hospital admission. It includes both the patient and a close relative, and may help improve how future care decisions are discussed.
Oslo, Bærum kommuneAges 70 years+ - NCT05686525Recruiting
TUMT vs PAE to ease severe urinary symptoms from an enlarged prostate
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
Copenhagen, Copenhagen NAges 40 years+ - NCT05703789Recruiting
Dental treatment for severe long-term eating disorders
This study focuses on people with severe eating disorders lasting many years and looks at dental needs, since these can lead to extensive tooth damage. You may be eligible if you need significant dental treatment on at least one jaw.
StockholmAges 18–50 - NCT05704881Recruiting
Using breath CO2 levels to judge COPD flare severity in ER
This study measures an easy breathing signal called end-tidal carbon dioxide (a CO2 reading from your exhaled breath) to help judge how severe a COPD flare is. It may help doctors decide how closely you need monitoring and treatment during emergency care.
Grenoble, IsèreAges 18 years+ - NCT05707975Recruiting
Support for teens with eco-anxiety and suicidal thoughts
This trial studies a program to help adolescents who feel eco-anxiety (distress about environmental issues) and may also be at risk for suicidal thoughts. It may help by testing an approach for teens during a hospital stay in child mental health care.
Bron, RhoneAges 12–16 - NCT05711485Recruiting
Test whole-blood transfusion plan for severe malaria in young children
This trial studies a platelet-focused strategy for giving whole blood to children under 5 with severe malaria. It aims to see whether this approach can improve care while keeping children safe.
Baltimore, MarylandAges 6 months–4.9 years - NCT05717192Recruiting
Bronchoscopy treatment to shrink severe emphysema using heat
This trial studies a bronchoscopy procedure that uses heat (thermoablation) to reduce over-inflated lung tissue in people with severe emphysema. If you qualify, it aims to improve breathing and walking ability after trying standard treatments first.
BerlinAges 40–75 - NCT05741411Recruiting
Text-and-phone support after concussion for teens
This study tests whether a phone-based (mHealth) handoff and follow-up can help teens after a concussion, especially those at higher risk of long-lasting symptoms. It uses smartphone check-ins and coordination between emergency and specialty care.
Philadelphia, PennsylvaniaAges 13–18 - NCT05765864Recruiting
Study of self-harm in at-risk teens
This study looks at self-harm and thoughts/behaviors related to safety in teenagers who are considered at higher risk. It may help researchers better understand what supports are needed for teens who self-harm without wanting to die.
LjubljanaAges 13–18 - NCT05778773Recruiting
Study of treatment outcomes for severe aortic valve narrowing
This study looks at how well current treatment choices work for older adults with severe aortic valve narrowing (stenosis). It may help doctors better understand what works best for aging patients in Italy.
San Donato Milanese, MIAges 65 years+ - NCT05788861Recruiting
Study for children with severe strep skin or bloodstream infection
This trial is for people under 18 who have a confirmed invasive Group A strep infection, meaning strep bacteria found in places that are normally sterile (like the blood or deep tissues). It tests whether a specific study approach can help improve outcomes for children with these serious infections.
CréteilAges 1 day–17 years
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,502 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.